Literature DB >> 3856096

Kinetics of divalent monoclonal antibody binding to tumour cell surface antigens using flow cytometry: standardization and mathematical analysis.

R Roe, R A Robins, R R Laxton, R W Baldwin.   

Abstract

Flow cytofluorimetric methods have been used to quantitate the interaction between a divalent monoclonal antibody and a tumour cell surface antigen. After standardization using fluorescein and 125I-labelled antibodies, kinetics of association and dissociation were measured, and antibody bound at equilibrium quantitated. A mathematical model was developed in conjunction with these experimental results which allowed the calculation of rates for monovalent association and monovalent and divalent dissociation, and a description of the contribution of each to the level of bound antibody at different antibody concns.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856096     DOI: 10.1016/0161-5890(85)90029-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Authors:  L G Durrant; V S Byers; P J Scannon; R Rodvien; K Grant; R A Robins; R A Marksman; R W Baldwin
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.

Authors:  H Yeoman; R A Robins
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

3.  What you need to know when you go with the flow: pitfalls in the use of flow cytometry.

Authors:  M Pallis; R A Robins
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

4.  Purification and properties of Myxococcus xanthus cell surface antigen 1604.

Authors:  B W Jarvis; M Dworkin
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

5.  Human non-lineage antigen, CD46 (HuLy-m5): purification and partial sequencing demonstrates structural homology with complement-regulating glycoproteins.

Authors:  D F Purcell; N J Deacon; S M Andrew; I F McKenzie
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.

Authors:  M R Price; S Edwards; E Jacobs; I Z Pawluczyk; V S Byers; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.

Authors:  J Morgan; A G Gray; E R Huehns
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

8.  A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.

Authors:  M V Pimm; R A Robins; M J Embleton; E Jacobs; A J Markham; A Charleston; R W Baldwin
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

9.  Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Authors:  L G Durrant; M C Garnett; J Gallego; N C Armitage; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

10.  Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.

Authors:  L G Durrant; K C Ballantyne; N C Armitage; R A Robins; R Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.